Sustained Acoustic Medicine Ultrasound Diathermy Clinical Performance
Phase 1
Completed
- Conditions
- Measurement of Diathermy on Anatomical Locations of the Body
- Registration Number
- NCT05259995
- Lead Sponsor
- ZetrOZ, Inc.
- Brief Summary
The purpose of this study is to measure diathermy performance of Sustained Acoustic Medicine Devices with commercially available ultrasound gel coupling patches.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
• Healthy Volunteer
Exclusion Criteria
- Is pregnant/nursing.
- Has an active infection, open sores, or wounds in the treatment area.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Ultrasound Diathermy (Degrees Centigrade) 0 - 4 hours Temperature Measurement On Body (Degrees Centigrade)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Sustained Acoustic Medicine's diathermy effects on tissue penetration and energy delivery?
How does Sustained Acoustic Medicine compare to standard ultrasound therapy in terms of diathermy performance and tissue heating efficiency?
Are there specific biomarkers that correlate with enhanced therapeutic response to Sustained Acoustic Medicine in targeted anatomical locations?
What adverse events have been reported in early-phase trials of Sustained Acoustic Medicine devices and how are they managed?
What are the potential applications of Sustained Acoustic Medicine in combination with other non-invasive therapeutic modalities for tissue treatment?
Trial Locations
- Locations (1)
ZetrOZ
🇺🇸Trumbull, Connecticut, United States
ZetrOZ🇺🇸Trumbull, Connecticut, United States